Ttk Healthcare Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ttk Healthcare Limited with three other
companies in this sector in India:
Shilpa Medicare Limited
sales of 7.33 billion Indian Rupees [US$102.82 million]
of which 98%
was Pharmaceutical products and services),
Sms Pharmaceuticals Limited
(4.65 billion Indian Rupees [US$65.18 million]
of which 100%
was Manufacturing and sale of Active Ingredi), and
Advanced Enzyme Technologies Ltd
(4.20 billion Indian Rupees [US$58.83 million]
of which 100%
was Manufacturing and sale of Enzymes).
Ttk Healthcare Limited reported sales of 6.28 billion Indian Rupees (US$88.03 million)
March of 2019.
increase of 8.7%
versus 2018, when the company's sales were 5.78 billion Indian Rupees.
Sales at Ttk Healthcare Limited have increased during each of the previous five years
(and since 2014, sales have increased a total of 51%).
Sales of Medical Devices saw an increase
that was more than double the company's growth rate: sales were up
31.3% in 2019, from
326.52 million Indian Rupees to 428.70 million Indian Rupees.
Ttk Healthcare Limited also saw significant increases in sales in
Pharmaceuticals (up 12.5% to 2.16 billion Indian Rupees)
Foods (up 11.5% to 747.01 million Indian Rupees)
Others (up 22.9% to 7.24 million Indian Rupees)